Matthew Winton - Apr 3, 2023 Form 3 Insider Report for Inozyme Pharma, Inc. (INZY)

Role: COO
Signature: /s/ Matthew Winton
Stock symbol: INZY
Transactions as of: Apr 3, 2023
Transactions value $: $0
Form type: 3
Date filed: 4/4/2023, 08:31 AM
Next filing: Mar 15, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit Index: 24.1 Power of Attorney